{"id":"W2588974371","doi":"10.1111/dom.12909","title":"Lipid‐lowering efficacy and safety of alirocumab in patients with or without diabetes: <scp>A</scp> sub‐analysis of <scp>ODYSSEY COMBO II</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Statin; Internal medicine; Adverse effect; Diabetes mellitus; Gastroenterology; Urology; Pharmacology; Endocrinology; Cholesterol; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001311319,0.0007698903,0.001526012,0.0002892298,0.0002377293,0.0008451105,0.000315698,0.0005729547,0.001638129],"category_scores_gemma":[0.00102597,0.0003409126,0.002052359,0.0002973098,0.0003185937,0.0003574583,0.0002733902,0.00132569,0.0002407438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005053005,"about_ca_system_score_gemma":0.000655062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007913961,"about_ca_topic_score_gemma":0.002015625,"domain_scores_codex":[0.9995292,0.0002025878,0.00006262772,0.00008419174,0.00005853935,0.00006277063],"domain_scores_gemma":[0.9990363,0.0001724891,0.0002798669,0.00007059004,0.00009867832,0.0003420836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8594565,0.007332495,0.05130403,0.001063501,0.007739546,0.0002310529,0.0001239852,0.0004864645,0.02721363,0.00007234912,0.001302992,0.04367331],"study_design_scores_gemma":[0.5153054,0.2020351,0.2588892,0.0001105335,0.01253338,0.0006472861,0.0001110672,0.001762337,0.005556136,0.0001170252,0.002861282,0.00007111966],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964737,0.002075047,0.0001338903,0.0001058601,0.00003387254,0.0002794396,0.0004066901,0.00001313324,0.0004783679],"genre_scores_gemma":[0.9968272,0.0008182895,0.0003503008,0.000348931,0.00009422479,0.000243574,0.0009214005,0.000005642096,0.0003903934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001638129,"threshold_uncertainty_score":0.006935,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008596369459351293,"score_gpt":0.2316953941564273,"score_spread":0.223099024697076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}